Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$46.97 -1.18 (-2.45%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Non-Current Deffered Revenue (2015 - 2020)

Updated

Rigel Pharmaceuticals (RIGL) posted Non-Current Deffered Revenue of $146,000 for Q3 2020, down 99.4% from $25.18 million a year earlier.

Analysis

Rigel Pharmaceuticals (RIGL) Non-Current Deffered Revenue (2015 - 2020) Analysis & Trends

At the end of FY2019, Rigel Pharmaceuticals' Non-Current Deffered Revenue came in at $1.4 million, down 0.3% from FY2018.

  • In prior years, Rigel Pharmaceuticals' Non-Current Deffered Revenue was $1.41 million in FY2018.
  • The Q3 2020 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rigel Pharmaceuticals 899.44 Mn 365.32 Mn 70.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 146,000.00
Mar 31, 2020 1.56 Mn
Dec 31, 2019 1.40 Mn
Sep 30, 2019 25.18 Mn
Jun 30, 2019 26.40 Mn
Mar 31, 2019 26.38 Mn
Dec 31, 2018 1.41 Mn
Jun 30, 2015 3.76 Mn
Mar 31, 2015 8.59 Mn
API Access

Rigel Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RIGL&period=max&api_key=YOUR_API_KEY